Intuitive Surgical (NASDAQ:ISRG) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says

Intuitive Surgical (NASDAQ:ISRG) had its price objective boosted by analysts at Stifel Nicolaus from $525.00 to $610.00 in a report released on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the medical equipment provider’s stock. Stifel Nicolaus’ price objective points to a potential upside of 10.83% from the stock’s current price.

Other equities analysts also recently issued reports about the company. BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Citigroup raised their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Finally, Leerink Partners increased their target price on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $541.33.

Intuitive Surgical Stock Up 0.5 %

Shares of ISRG stock opened at $550.41 on Thursday. The stock’s 50-day moving average price is $514.78 and its 200 day moving average price is $472.60. The stock has a market capitalization of $196.04 billion, a PE ratio of 88.49, a price-to-earnings-growth ratio of 5.33 and a beta of 1.38. Intuitive Surgical has a 52-week low of $307.72 and a 52-week high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Analysts expect that Intuitive Surgical will post 5.45 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. This represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 51,023 shares of company stock valued at $26,384,247 in the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several hedge funds have recently added to or reduced their stakes in the business. Hazlett Burt & Watson Inc. lifted its holdings in Intuitive Surgical by 5.8% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after acquiring an additional 20 shares during the last quarter. Mitchell Mcleod Pugh & Williams Inc. lifted its stake in Intuitive Surgical by 4.1% during the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after purchasing an additional 20 shares during the last quarter. Ullmann Wealth Partners Group LLC grew its position in Intuitive Surgical by 1.6% in the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after buying an additional 21 shares during the last quarter. Meeder Advisory Services Inc. increased its holdings in shares of Intuitive Surgical by 0.3% in the third quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock valued at $3,629,000 after buying an additional 22 shares in the last quarter. Finally, One Wealth Management Investment & Advisory Services LLC lifted its position in shares of Intuitive Surgical by 3.4% during the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after acquiring an additional 23 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.